Last quarter (Q4 2024), Mindbio Therapeutics Corp.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Mindbio Therapeutics Corp.'s net income was $-45.82K. See Mindbio Therapeutics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24
Jun 23
Total Revenue
$ ―
$ ―
Gross Profit
$ ―
$ ―
Operating Expenses
$ ―
$ ―
Depreciation and Amortization
$ ―
$ ―
EBITDA
$ -56.64K
$ -4.25M
Operating Income
$ -55.95K
$ ―
Other Income/Expenses
$ ―
$ ―
Pretax Income
$ ―
$ ―
Net Income
$ -415.64K
$ ―
Per Share Metrics
Basic EPS
$ ―
$ ―
Diluted EPS
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
Currency in USD
Mindbio Therapeutics Corp. Earnings and Revenue History